BNP/CALL/STRYKER CORP./380/0.1/17.01.25 Stock

Warrant

DE000PN5BB07

Delayed Deutsche Boerse AG 12:50:39 2024-06-20 EDT
1.2 EUR -21.05% Intraday chart for BNP/CALL/STRYKER CORP./380/0.1/17.01.25
Current month+28.81%
1 month+46.15%
Date Price Change
24-06-20 1.2 -21.05%
24-06-19 1.52 +7.80%
24-06-18 1.41 +11.90%
24-06-17 1.26 -0.79%
24-06-14 1.27 +4.96%

Delayed Quote Deutsche Boerse AG

Last update June 20, 2024 at 12:50 pm

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying STRYKER CORPORATION
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PN5BB0
ISINDE000PN5BB07
Date issued 2023-06-27
Strike 380 $
Maturity 2025-01-17 (211 Days)
Parity 10 : 1
Emission price 1.11
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 2.78
Lowest since issue 0.37
Spread 0.05
Spread %3.97%

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
348.7 USD
Average target price
372.9 USD
Spread / Average Target
+6.96%
Consensus